Company intelligence / Profile preview
Klotho Therapeutics
San Diego, California, United Statesklotho.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company has demonstrated significant reduction in risk of chronic kidney disease and acute renal failure in animal models. Multiple studies have shown that treatment with Klotho protein increases lifespan and promotes cognitive function in Klotho deficient mice and animal models of Alzheimer's disease and premature aging.
- Therapeutic areas
- NephrologyOncologyEndocrinologyOtherNeurology
- Modalities
- Protein drugsgene therapiescell therapies
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Klotho Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Klotho Therapeutics.